In the Perspective entitled “Oral Anticoagulants to Prevent Stroke in Nonvalvular Atrial Fibrillation in Patients With CKD Stage 5D: An NKF-KDOQI Controversies Report” that appeared in the December 2017 issue of AJKD (Bansal et al, volume 70, issue 6, pages 859-868), some corrections are needed to resolve ambiguities in the content related to warfarin alternatives.